Yifan Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002019.SZ

Yifan Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 45.52%

Yifan Pharmaceutical Co., Ltd. Gross Profit Margin is 45.52% for the year ending December 31, 2023, a -6.40% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Yifan Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 48.63%, a 17.28% change year over year.
  • Yifan Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 41.47%, a -10.77% change year over year.
  • Yifan Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 46.48%, a 0.75% change year over year.
  • Yifan Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 46.13%, a 4.66% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Shenzhen Stock Exchange: 002019.SZ

Yifan Pharmaceutical Co., Ltd.

CEO Mr. Xian Feng Cheng
IPO Date July 13, 2004
Location China
Headquarters No. 50, Qinshan
Employees 4,230
Sector Health Care
Industries
Pharmaceuticals Cosmetics
Description

Yifan Pharmaceutical Co., Ltd. produces and sells drugs and medicines in China and internationally. It provides drugs across gynecology, pediatrics, orthopedics, and dermatology therapeutic areas; therapeutic infusion solutions; and pantothenic acid and Provitamin B5 products. The company also provides Chinese traditional medicines, women's health products, and blood tumor drugs. In addition, it offers APIs, including feed additives/animal health products, skin and hair care ingredients, functional food additives, and fine chemicals; and PBAT/PBS biodegradable resins and PVB films. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is based in Hangzhou, China.

Similar companies

002030.SZ

Daan Gene Co., Ltd.

USD 0.79

3.04%

002038.SZ

Beijing SL Pharmaceutical Co., Ltd.

USD 1.04

1.87%

002001.SZ

Zhejiang NHU Company Ltd.

USD 2.97

0.01%

000999.SZ

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

USD 5.92

1.98%

002007.SZ

Hualan Biological Engineering Inc.

USD 2.17

2.25%

StockViz Staff

January 15, 2025

Any question? Send us an email